Stanley C. Chamberlain

Statistics

Publications

Citations

466

H-Index

Active since

2002

Affiliations

Research Triangle Park Foundation(Current)

University of Michigan

GlaxoSmithKline (United States)

Stanley C. Chamberlain is an author at Research Triangle Park Foundation specializing in pharmacology, molecular virology, and treatment of cytomegalovirus infection.

Publications per year

2002–2002

Publications

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Stanley C. Chamberlain, Steven S. Good et al. · Antimicrobial Agents and Chemotherapy · 2002 · 364 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Preclinical and Toxicology Studies of 1263W94, a Potent and Selective Inhibitor of Human Cytomegalovirus Replication

George W. Koszalka, Nelson Johnson, Steven S. Good et al. · Antimicrobial Agents and Chemotherapy · 2002 · 102 citations · Full text

Pharmacy, Pharmacology, Toxicology +16

1–2 of 2